3140 results for «2050»
3140 results
Redefining and optimising LAA closure - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Boston Scientific
A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.
She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...
Welcome to PCR Rio Valves 2025
11 Sep 2025 – From PCR Rio Valves 2025
Watch the opening ceremony of the very first edition of PCR Rio Valves! Experience the excitement as this inaugural 2-day Course kicks off. Hear introductions in English, Portuguese, and Spanish, meet the Course Directors, Programme Committee, and Faculty, explore the rich program in detail, and get...
CT analysis - Be ready for our LIVE Educational cases on TAVI
11 Sep 2025 – From PCR Rio Valves 2025
Prepare for live educational cases on transcatheter aortic valve implantation (TAVI) by mastering CT analysis techniques. This session guides you through obtaining and measuring the aortic annulus, interpreting the crucial aortic annulus S-curve, and understanding the views necessary along this curve for successful TAVI procedures.
Watch related...
Mastering tricuspid TEER - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 77-year-old male with atrial fibrillation and chronic kidney disease presented with symptomatic severe atrial tricuspid regurgitation.He underwent implantation of two TriClip XTW devices (antero-septal and postero-septal) under general anesthesia, guided by transesophageal echocardiography (TEE).
LIVE Educational Case from Bordeaux University Hospital - Bordeaux, France
Navigate the video...
How to optimise outcome in valve-in-valve and valve-in-mitral annular calcification patients
12 Sep 2025 – From PCR Rio Valves 2025
This session explores how to optimise outcomes in valve-in-valve and valve-in-mitral annular calcification procedures. Clinical evidence is combined with real case demonstrations, highlighting step-by-step approaches, practical strategies, and techniques to reduce risks such as left ventricular outflow tract obstruction in high-risk patients.
Redo TAVI
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on the challenges and strategies of redo TAVI, from careful planning to valve selection and tailored procedural approaches. Learn how to manage different valve platforms, optimise outcomes in valve-in-valve scenarios, and prevent complications such as coronary obstruction through real case discussions.
Addressing challenges in the right heart
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses complex challenges associated with right heart conditions, featuring cases such as post-infarction interventricular septal defect with right heart failure, innovative orthotopic options for tricuspid regurgitation, and advanced edge-to-edge repair using the TRICLIP device. Gain insight into therapeutic strategies for managing severe tricuspid insufficiency...
Management of aortic stenosis: what really matters before and after the procedure
11 Sep 2025 – From PCR Rio Valves 2025
Aortic stenosis management is a lifetime strategy, not a one-time procedure. This session covers key decision-making factors, compares surgical and transcatheter options, and provides guidance on post-procedural care. Learn to individualise treatment based on age, anatomy, and risk, and plan interventions with the patient’s long-term trajectory...
Tricuspid valve - Present and future perspectives: a critical appraisal
12 Sep 2025 – From PCR Rio Valves 2025
Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...
Structural heart: demanding anatomies, difficult situations and unusual strategies
12 Sep 2025 – From PCR Rio Valves 2025
Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.
A 24.5 mm Myval valve was implanted without...
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Left atrial appendage occlusion
02 Oct 2025
This PCR Textbook chapter reviews the underlying concepts involving atrial fibrillation, outlines anticoagulation strategies for thromboembolism prevention, and describes the current state and future directions of left atrial appendage occlusion.
Authors :
Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial
06 Mar 2023
Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
